Trial Profile
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2023
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Glipizide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Hyper
- 29 Nov 2023 The protocol has been amended as above- 1) Number of treatment arms has been changed from 2 to 4. 2) Actual number of patients has been changed from 23 to 72.
- 02 Oct 2023 Status changed from active, no longer recruiting to completed.
- 26 Jun 2023 Results (n=24) presented at the 83rd Annual Scientific Sessions of the American Diabetes Association